ICI 204,448

CAS No. 121264-04-8

ICI 204,448( —— )

Catalog No. M33869 CAS No. 121264-04-8

ICI 204,448 is a potent κ-opioid agonist with potential analgesic activity for the study of neurological diseases.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 73 In Stock
5MG 107 In Stock
10MG 170 In Stock
25MG 273 In Stock
50MG 417 In Stock
100MG 588 In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    ICI 204,448
  • Note
    Research use only, not for human use.
  • Brief Description
    ICI 204,448 is a potent κ-opioid agonist with potential analgesic activity for the study of neurological diseases.
  • Description
    ICI-204448 is a κ-opioid agonist with limited access to the CNS, ICI-204448 can displace the binding of the kappa-opioid ligand 3H-bremazocine from guinea pig cerebellum membranes.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Endocrinology/Hormones
  • Target
    Opioid Receptor
  • Recptor
    Opioid Receptor
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    121264-04-8
  • Formula Weight
    501.83
  • Molecular Formula
    C23H27Cl3N2O4
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : 125 mg/mL (249.09 mM; Ultrasonic )
  • SMILES
    Cl.O=C(O)COC1=CC=CC(=C1)C(N(C(=O)CC2=CC=C(Cl)C(Cl)=C2)C)CN3CCCC3
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. J S Shaw, et, al. ICI 204448: a kappa-opioid agonist with limited access to the CNS. Br J Pharmacol. 1989, 96, 4.?
molnova catalog
related products
  • TAN-67 dihydrobromid...

    A potent and selective δ-opioid receptor agonist that has high affinity and selectivity for the δ1 subtype with Ki of 1.12 nM.

  • Hemorphin-7

    Hemorphin-7 binds to the angiotensin IV receptor, triggering multiple effects including cellular proliferation and memory enhancement. Hemorphins are endogenous peptides belonging to the family of atypical opioid peptides released from hydrolyzed hemoglobin. Hemorphin-7 is investigated as a potential biomarker for breast cancer.

  • LY-2940094

    LY-2940094 decreases ethanol self-administration in animal models.